TY  - GEN
AU  - Grassi,C
AU  - Casali,L
AU  - Curti,E
AU  - Tellarini,M
AU  - Lazzaro,C
AU  - Schito,G
TI  - Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB)
SN  - 1120-009X
PY  - 2003///0528
KW  - Acute Disease
KW  - Aged
KW  - Anti-Infective Agents
KW  - administration & dosage
KW  - Aza Compounds
KW  - Bronchitis, Chronic
KW  - drug therapy
KW  - Ceftriaxone
KW  - Costs and Cost Analysis
KW  - Female
KW  - Fluoroquinolones
KW  - Humans
KW  - Italy
KW  - Male
KW  - Middle Aged
KW  - Moxifloxacin
KW  - National Health Programs
KW  - economics
KW  - Quinolines
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1179/joc.2002.14.6.597
ER  -